Form 4: Copart Director Matt Blunt Granted Stock Options

Copart Director Matt Blunt was granted 17,813 stock options with an exercise price of $38.72, vesting monthly over 12 months.

Summary

• Matt Blunt, a Director at Copart, Inc. (CPRT), was granted 17,813 stock options.
• The options have an exercise price of $38.72 per share.
• These options were granted on December 5, 2025, under the 2007 Equity Incentive Plan.
• The options will vest on a monthly basis over the 12 months succeeding the grant date.
• The expiration date for these options is December 5, 2032.
• Following this transaction, Matt Blunt beneficially owns 17,813 direct stock options.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is generally a positive signal, aligning management incentives with shareholder interests. It's a routine compensation event, not indicative of extraordinary positive or negative news.

Positives

• The grant of stock options to a director aligns their interests with shareholders, incentivizing long-term performance.
• The options were granted under an existing equity incentive plan (2007 Equity Incentive Plan), indicating a structured approach to executive compensation.

Future Outlook

The grant of stock options suggests a long-term incentive for the director, aligning future performance with shareholder value over the vesting and exercise period.

Industry Context

The grant of stock options is a standard practice in corporate compensation, particularly for directors, to align their interests with the company's long-term performance. This is common across various industries, including the vehicle auction and remarketing sector where Copart operates.

Comparison to Industry Standards

• The grant of stock options to directors is a common compensation practice.
• Without specific details on Copart's peer group compensation structures or the company's performance relative to competitors like IAA, Inc. (IAA) or KAR Auction Services (KAR), a direct comparison of the specific grant size or exercise price to industry benchmarks is not feasible from this filing alone. However, the use of an equity incentive plan is standard for publicly traded companies.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of director's interests with long-term company performance.

Next Steps

• The options will vest monthly over the 12 months following the grant date of December 5, 2025.
• Matt Blunt may exercise these options at any time after vesting and before the expiration date of December 5, 2032.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to a director as part of their compensation. While it aligns the director's interests with long-term shareholder value, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard compensation event.

Keywords

Copart, CPRT, Stock Options, Director Compensation, Equity Incentive Plan, Insider Transaction, Form 4, Matt Blunt